Dr Kulasekararaj's interests include understanding biological pathways and ineffective erythropoiesis in low risk MDS and BMF. His presentation will cover therapeutic advances and promising new agents in advance phase 2 and phase 3 trials.
Dr Austin Kulasekararaj
Dr Kulasekararaj leads the King’s National PNH service with his special interest in bone marrow failure syndromes - aplastic anaemia, PNH and myelodysplastic syndrome. His research interest is in molecular pathogenesis of myelodysplastic syndromes (MDS), especially the role of TP53 and other somatic mutations and he will be presenting on AML and MDS.
Dr Kulasekararaj is visiting Melbourne as an Expert-In-Residence of Melbourne Genomics Health Alliance.
Can't attend in person? Register for Webinar